-
The lancet oncology · Sep 2021
Comment LetterPembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer - Authors' reply.
- Arjun V Balar, Ashish M Kamat, Ronald de Wit, and KEYNOTE-057 investigators.
- Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA. Electronic address: arjun.balar@nyulangone.org.
- Lancet Oncol. 2021 Sep 1; 22 (9): e380.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:

- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.